Zobrazeno 1 - 10
of 171
pro vyhledávání: '"K. Mangat"'
Autor:
Kimberly M. L. Gan, Ju-Lee Oei, Im Quah-Smith, Azanna A. Kamar, Alexis A. D. Lordudass, Kian D. Liem, Kwee Bee Lindrea, Mary Daly, Nilima Gaunker, Avneet K. Mangat, Maryna Yaskina, Georg M. Schmölzer
Publikováno v:
Frontiers in Pediatrics, Vol 8 (2020)
Background: Eye exam for Retinopathy of prematurity (ROP) is a painful procedure and pharmacological analgesia might be ineffective. We hypothesized that magnetic auricular acupuncture (MAA) compared to placebo will decrease pain during ROP exam in p
Externí odkaz:
https://doaj.org/article/39030b5f9557499a80d5877d2b9d677e
Autor:
Robin L. Walker, William A. Ghali, Guanmin Chen, Tej K. Khalsa, Birinder K. Mangat, Norm R. C. Campbell, Elijah Dixon, Doreen Rabi, Nathalie Jette, Robyn Dhanoa, Hude Quan
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background With high-quality community-based primary care, hospitalizations for ambulatory care sensitive conditions (ACSC) are considered avoidable. The purpose of this study was to test the inter-physician reliability of judgments of avoid
Externí odkaz:
https://doaj.org/article/d1c74212b79748d695cec2eb0a48ec25
Autor:
Eugene R. Ahn, Michael Rothe, Pam K. Mangat, Elizabeth Garrett-Mayer, Hussein M. Ali-Ahmad, John Chan, Michael L. Maitland, Sapna R. Patel, Zachary Reese, Ani S. Balmanoukian, Charles W. Drescher, Rui Li, Apostolia M. Tsimberidou, Charles A. Leath, Raegan O'Lone, Gina N. Grantham, Susan Halabi, Richard L. Schilsky
Publikováno v:
JCO Precision Oncology.
PURPOSE The TAPUR Study is a pragmatic basket trial evaluating antitumor activity of commercially available targeted agents in patients with advanced cancers harboring potentially actionable genomic alterations. Data from a cohort of patients with en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::588066580c3b6f14e2e0ec6ccbb50659
https://doi.org/10.1200/po.22.00609
https://doi.org/10.1200/po.22.00609
Autor:
Eddy S. Yang, Susan Halabi, Michael Rothe, Elizabeth Garrett-Mayer, Pam K. Mangat, Evan Pisick, Elie Dib, Earle F. Burgess, Michael Zakem, Nitin Rohatgi, Mehmet A. Bilen, Raegan O'Lone, Gina N. Grantham, Richard L. Schilsky
Publikováno v:
JCO Precision Oncology.
PURPOSE The TAPUR Study is a phase II basket trial that aims to evaluate activity of approved targeted agents in patients with advanced cancers with potentially actionable genomic variants. Data from a cohort of patients with metastatic castrate-resi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6d9e250e0ae7b39ca57bb0a8442c548
https://doi.org/10.1200/po.22.00505
https://doi.org/10.1200/po.22.00505
Autor:
Arshdeep Singh Chahal, Rabinder Kaur, P S Shera, Sudhendu Sharma, Ankita Thakur, H K Mangat, A Mohanasundaram
Publikováno v:
Indian Journal of Entomology. :1-3
A survey was conducted to record the diversity of lac insect Kerria lacca (Kerr) associated natural enemies (predators/ parasitoids) during 2019-2020. In katki crop, the abundance of natural enemies ranged from 1.08 to 44.09%. There were three parasi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac160296ff6b6e6efa18cd2a9348812d
https://doi.org/10.55446/ije.2022.583
https://doi.org/10.55446/ije.2022.583
Autor:
Erhard Reschenhofer, Manveer K. Mangat
Publikováno v:
Econometrics, Vol 8, Iss 4, p 40 (2020)
For typical sample sizes occurring in economic and financial applications, the squared bias of estimators for the memory parameter is small relative to the variance. Smoothing is therefore a suitable way to improve the performance in terms of the mea
Externí odkaz:
https://doaj.org/article/9a2f0b1270b24a5ebeaf40aa161e6dc6
Autor:
Kelsey A, Klute, Michael, Rothe, Elizabeth, Garrett-Mayer, Pam K, Mangat, Reza, Nazemzadeh, Kathleen J, Yost, Herbert L, Duvivier, Eugene R, Ahn, Timothy L, Cannon, Olatunji B, Alese, John C, Krauss, Ramya, Thota, Carmen J, Calfa, Crystal S, Denlinger, Raegan, O'Lone, Susan, Halabi, Gina N, Grantham, Richard L, Schilsky
Publikováno v:
JCO precision oncology. 6
TAPUR is a phase II basket trial evaluating the antitumor activity of commercially available targeted agents in patients with advanced cancer and genomic alterations known to be drug targets. The results of a cohort of patients with colorectal cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::134a3ce9ac03269272d5a5172a238eb2
https://pubmed.ncbi.nlm.nih.gov/36409971
https://pubmed.ncbi.nlm.nih.gov/36409971
Autor:
Ranju Gupta, Funda Meric-Bernstam, Michael Rothe, Elizabeth Garrett-Mayer, Pam K. Mangat, Stacy D'Andre, Eugene R. Ahn, Raegan O'Lone, Susan Halabi, Gina N. Grantham, Richard L. Schilsky
Publikováno v:
JCO Precision Oncology.
PURPOSE The TAPUR Study is a pragmatic phase II basket trial evaluating antitumor activity of commercially available targeted agents in patients with advanced cancers harboring potentially actionable genomic alterations. Data from two cohorts of pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17c6f744a1fdbb0361d6f061e55cc038
https://doi.org/10.1200/po.22.00306
https://doi.org/10.1200/po.22.00306
Autor:
Herbert Chan, Jeffrey R. Brubacher, John A. Staples, Shannon Erdelyi, Birinder K. Mangat, Mitchell Vu
Publikováno v:
The American Journal of Emergency Medicine. 55:196-198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4d0cd18c0204f13eaa7fec4f7a43eb6
https://doi.org/10.1016/j.ajem.2021.06.025
https://doi.org/10.1016/j.ajem.2021.06.025
Autor:
Pam K. Mangat, Suanna S. Bruinooge, Timothy L. Cannon, Sagun Shrestha, Nicole L. Butler, Julie Gottlieb Fisher, Andrew L. Rygiel, Sasha L. Warren, Damien Hansra, Carmen Julia Calfa, Richard L. Schilsky, Ajjai Alva, Eugene R Ahn, Susan Halabi, Maged F. Khalil, Shamika Ranasinghe, Pamela A. Crilley, Elizabeth Garrett-Mayer, Kaitlyn R. Antonelli, Derrick S. Haslem
Publikováno v:
Journal of Clinical Oncology. 39:2443-2451
PURPOSE The TAPUR Study is a phase II basket trial that aims to identify signals of antitumor activity of commercially available targeted agents in patients with advanced cancers harboring genomic alterations known to be drug targets. Results in a co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0d11946030606eb338dcd7d63df0e61
https://doi.org/10.1200/jco.20.02923
https://doi.org/10.1200/jco.20.02923